If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Additional Central Bank Development Revenues

15 Jun 2022 07:00

RNS Number : 8888O
Spectra Systems Corporation
15 June 2022
 

Spectra Systems Corporation

June 15, 2022

 

Spectra Systems Corporation ("Spectra")

Additional Central Bank Development Revenues

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, is pleased to announce that it has executed an amendment to a contract with a central bank customer (previously announced on 2 February and 21 April 2021), increasing the sensor development phase revenues by an additional $2mm. The contract is related to expanding the flexibility of use for the new sensors being developed.

Dr. Nabil Lawandy, Chief Executive Officer, stated: "We continue to provide cutting edge capabilities to our central bank customers who depend on us to respond quickly and effectively to their increasing requirements. This additional contract will increase the development phase from $8.8MM to $10.8MM while maintaining the existing timeline for sensor manufacturing and further solidifies our long-standing relationship with this central bank customer."

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

WH Ireland Limited (Nominated Adviser and Joint Broker)

Chris Fielding (Head of Corporate Finance)

Fraser Marshall (Head of Capital Markets)

Aimee McCusker (Corporate Broking Director)

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 7220 1650

 

 

 

 

Tel: +44 (0)20 3328 5665

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANKLFENAEFA
Date   Source Headline
22nd Jun 20172:18 pmRNSPosting of Annual Report and Accounts
18th May 20173:47 pmRNSExercise of Options
5th May 20172:01 pmRNSExercise of Options
13th Apr 201711:26 amRNSExercise of Options
30th Mar 20177:00 amRNSPreliminary Results
17th Mar 20177:00 amRNSAppointment of Chief Financial Officer
23rd Jan 20177:00 amRNSAppointment of Chief Financial Officer
4th Jan 20177:00 amRNSTrading Update
5th Dec 20167:00 amRNSResignation of Chief Financial Officer
1st Dec 20167:00 amRNSAnnual General Meeting Postponed
3rd Oct 20167:00 amRNSNew Five Year Contract with G7 Central Bank
21st Sep 20165:06 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSInterim Results for 6 Months ended 30 June 2016
7th Sep 20167:00 amRNSInterim Results Pre-announcement
24th Jun 20167:00 amRNSPosting of Annual Report and Accounts
31st May 20167:00 amRNSGrant of share options
25th May 20165:12 pmRNSHolding(s) in Company
5th May 20167:00 amRNSFirst TruBrand customer
18th Apr 20169:41 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSPreliminary Results
16th Feb 20167:00 amRNSExpected grant of share options
8th Feb 20167:00 amRNSTrading update and expected grant of share options
29th Jan 20167:00 amRNS$3m Acquisition of Key Specialty Phosphour Assets
27th Jan 20164:01 pmRNSHolding(s) in Company
17th Dec 20154:34 pmRNSRemoval of Restrictions from Common Stock
30th Nov 20157:00 amRNSHolding(s) in Company
17th Nov 20157:00 amRNSAGM Postponement
4th Nov 20154:28 pmRNSHolding(s) in Company
4th Nov 20151:57 pmRNSRemoval of Restrictions from Common Stock
16th Oct 20159:53 amRNSRemoval of Restrictions from Common Stock
2nd Oct 20153:17 pmRNSNotice of AGM
10th Sep 20152:30 pmRNSHolding(s) in Company
1st Sep 20154:41 pmRNSSettlement of Common Shares
1st Sep 20157:03 amRNSInterim results for 6 months ended 30 June 2015
14th Aug 20152:42 pmRNSRemoval of Restrictions from Common Stock
14th Aug 20157:00 amRNSModified Covert Materials Supply Contract
3rd Jul 20157:00 amRNSHolding(s) in Company
2nd Jul 20157:00 amRNSContract Win
19th Jun 201511:17 amRNSPosting of Annual Report and Accounts
16th Jun 20154:06 pmRNSRemoval of Restrictions from Common Stock
19th May 20158:46 amRNSRemoval of Restrictions from Common Stock
18th May 20153:50 pmRNSHolding(s) in Company
22nd Apr 20157:31 amRNSPreliminary Results
2nd Apr 20153:05 pmRNSRemoval of Restrictions from Common Stock
19th Mar 20152:23 pmRNSRemoval of Restrictions from Common Stock
5th Mar 20158:40 amRNSHolding(s) in Company
10th Feb 20157:00 amRNSContract Win
3rd Feb 20158:02 amRNSHolding(s) in Company
23rd Dec 20144:35 pmRNSHolding(s) in Company
9th Dec 20147:00 amRNSNotice of Allowance from the US Patent Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.